This NDC is on FDA's drug shortage list (posted Jun 13, 2018)
Product Information
LIDOCAINE HCL 1% VIAL is a generic product labeled by Hikma Pharmaceuticals USA Inc., priced at $0.0694 per ML under NDC 00143957710. Its NADAC has been published 275 times since May 20, 2020.
FDA first approved this application before 1982. Its Orange Book therapeutic-equivalence code is AP.
Strength
10 mg/mL
Manufacturer
Hikma Pharmaceuticals USA Inc.NDC
00143957710
Classification
Generic
Dosage Form
INJECTION, SOLUTION
Route
INFILTRATION; PERINEURAL
Effective Date
8/19/2026
Active Ingredients
LIDOCAINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA080407FDA Approved
Before 1982
TE Code
AP
On Market Since
2/14/1972
Pharmacological Classes
Price Statistics
The NADAC for LIDOCAINE HCL 1% VIAL has been published 275 times since May 20, 2020, and over the history we have for it it has risen 3.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0694 per ML |
|---|---|
| All-time high | $0.0853 (Apr 10, 2024) |
| All-time low | $0.0582 (Oct 18, 2023) |
| 52-week high | $0.0769 |
| 52-week low | $0.0681 |
| Median price | $0.0706 |
| Average price | $0.0696 |
| Largest weekly change | +46.6% (Dec 20, 2023) |
| Weeks tracked | 275 |
| Tracking since | May 20, 2020 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 3% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of LIDOCAINE HCL 1% VIAL?
The current National Average Drug Acquisition Cost (NADAC) for LIDOCAINE HCL 1% VIAL, manufactured by Hikma Pharmaceuticals USA Inc., is $0.0694 per ML (NDC 00143957710), effective Aug 19, 2026.
How has the price of LIDOCAINE HCL 1% VIAL changed over time?
Over the history we have for it, the NADAC for LIDOCAINE HCL 1% VIAL has risen 3.5%. It has been tracked across 275 weekly CMS publications since May 20, 2020.
What are the highest and lowest recorded NADAC prices for LIDOCAINE HCL 1% VIAL?
Since May 20, 2020, the NADAC for LIDOCAINE HCL 1% VIAL has ranged from a low of $0.0582 (Oct 18, 2023) to a high of $0.0853 (Apr 10, 2024), with a median of $0.0706 per ML.
Are there cheaper alternatives to LIDOCAINE HCL 1% VIAL?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LIDOCAINE HCL 1% 300 MG/30 ML, is $0.0674 per ML — about 3% below LIDOCAINE HCL 1% VIAL.
Who manufactures LIDOCAINE HCL 1% VIAL?
LIDOCAINE HCL 1% VIAL (NDC 00143957710) is labeled by Hikma Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Is LIDOCAINE HCL 1% VIAL in shortage?
Yes — NDC 00143957710 is currently listed in FDA's drug shortage database (posted Jun 13, 2018).